National Hospital Organization Osaka Toneyama Medical Center

Toyonaka-shi 560-8552

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling